ROSATOM plans to establish a subsidiary to market its technologies for nuclear medicine and irradiation and sterilization centres
16 January 2017 | World Nuclear News

ROSATOM plans to establish a subsidiary to market its technologies for nuclear medicine and irradiation and sterilization centres. According to a report by RIA Novosti, citing an unnamed source at the state nuclear corporation, the new company - Rusatom Healthcare - will have an authorised capital of RUB480 million ($8 million). It will be 100% owned by Atomenergoprom, the holding company that manages Russia's civilian nuclear assets.

Back